Raindance Technologies said this week that it has appointed Sirshendu Roopom Banerjee as president and CEO.
Banerjee was most recently director of healthcare investment banking at Leerink Swann, where he led the life science tools and diagnostics sector. Previously, Banerjee was with McKinsey and Goldman Sachs, where he advised Fortune 500 healthcare companies on corporate and growth strategy, product development, launch strategy, international expansion, and mergers and acquisitions.
Earlier in his career, Banerjee worked at Dana Farber Cancer Institute, the Whitehead Institute/MIT Human Genome Project, and the Massachusetts General Hospital Cancer Center. He holds a master's degree in public policy from the Kennedy School of Government at Harvard University and dual BS degrees in biology and economics from MIT.
Christopher McNary, who has served as RainDance CEO since Nov. 2007, will become chief commercial officer.